These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 209000)
1. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment. Shapiro IM; Andersson-Anvret M; Klein G Intervirology; 1978; 10(2):94-101. PubMed ID: 209000 [TBL] [Abstract][Full Text] [Related]
2. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin. Shapiro IM; Luka J; Andersson-Anvret M; Klein G Intervirology; 1979; 12(1):19-25. PubMed ID: 227812 [TBL] [Abstract][Full Text] [Related]
3. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids. Klein G; Clements G; Zeuthen J; Westman A Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751 [TBL] [Abstract][Full Text] [Related]
4. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. Moar MH; Ber R; Klein G; Westman A; Eriksson I Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545 [TBL] [Abstract][Full Text] [Related]
5. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle. Klein G; Clements G; Zeuthen J; Westman A Int J Cancer; 1976 Jun; 17(6):715-24. PubMed ID: 59708 [TBL] [Abstract][Full Text] [Related]
6. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D Intervirology; 1975; 5(6):319-34. PubMed ID: 181343 [TBL] [Abstract][Full Text] [Related]
7. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus. Fresen KO; zur Hausen H Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of D and R components of Epstein-Barr virus early antigen after superinfection and after induction with 5-iododeoxyuridine. Simonová I; Závadová H; Vonka V Acta Virol; 1977 May; 21(3):184-8. PubMed ID: 18915 [TBL] [Abstract][Full Text] [Related]
9. Spontaneous interferon production and Epstein-barr virus antigen expression in two human lymphoid cell lines and their somatic cell hybrids. Lidin B; Adams A Intervirology; 1975; 5(3-4):205-15. PubMed ID: 172473 [TBL] [Abstract][Full Text] [Related]
10. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids. Klein G; Vilcek J J Gen Virol; 1980 Jan; 46(1):111-7. PubMed ID: 6243338 [TBL] [Abstract][Full Text] [Related]
11. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus. Lidin BI; Lamon EW Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934 [TBL] [Abstract][Full Text] [Related]
12. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines. Boguszaková L; Hirsch I; Brichácek B; Vonka V J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308 [TBL] [Abstract][Full Text] [Related]
13. Host cell regulation of induction of Epstein-Barr virus. Glaser R; Nonoyama M J Virol; 1974 Jul; 14(1):174-6. PubMed ID: 4365330 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells. zur Hausen H; Fresen KO IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522 [TBL] [Abstract][Full Text] [Related]
15. Effect of adenine arabinoside on Epstein-Barr virus in vitro. Coker-Vann M; Dolin R J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542 [TBL] [Abstract][Full Text] [Related]
16. Complementation between infecting Epstein-Barr virus and intrinsic viral genomes in human lymphoid cell lines. Lidin BI; Lamon EW; Cloud G; Soong SJ Intervirology; 1982; 18(1-2):66-75. PubMed ID: 6288617 [TBL] [Abstract][Full Text] [Related]
17. Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. Klein G; Zeuthen J; Terasaki P; Billing R; Honig R; Jondal M; Westman A; Clements G Int J Cancer; 1976 Nov; 18(5):639-52. PubMed ID: 62724 [TBL] [Abstract][Full Text] [Related]
18. Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity. Mitrani-Rosenbaum S; Ber R; Goldblum N; Povey S; Gamliel H; Ben-Bassat H Int J Cancer; 1982 Nov; 30(5):593-600. PubMed ID: 6295967 [TBL] [Abstract][Full Text] [Related]
19. Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV. Cho MS; Fresen KO; zur Hausen H Int J Cancer; 1980 Sep; 26(3):357-63. PubMed ID: 6270006 [TBL] [Abstract][Full Text] [Related]
20. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV. Fresen KO; Cho MS; zur Hausen H Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]